SAFE-BioPharma started in 2003 when a volunteer taskforce of biopharmaceutical company IT professionals developed a way for industry to manage cyber-identities and to use those identities to apply a higher form of electronic signature to electronic documents.
In conjunction with the US CIO Council, the FDA and the EU EMA, they established the SAFE-BioPharma digital identity and signature standard, providing standardized, high-assurance identity trust for cyber-transactions across the biopharmaceutical and healthcare sectors.
They also created SAFE-BioPharma Association, the not-for-profit industry coalition that manages the SAFE-BioPharma standard.
Our member companies fund the ongoing development and implementation of the SAFE-BioPharma standard and utilize the standard for a broad range of purposes.
Our mission is to help industry protect its substantial information assets, move its business processes online, and become paperless in order to improve productivity, reduce costs, and lower time to market.